Spain· ES:1191408007
SUNOSI 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
A medicinal product containing producto con solriamfetol, registered in Spain by Atnahs Pharma Netherlands Bv..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- producto con solriamfetol
- Manufacturer
- Atnahs Pharma Netherlands Bv.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Producto con solriamfetol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSUNOSIAtnahs Pharma Netherlands B.V., Amsterdam
- FinlandSunosiAtnahs Pharma Netherlands B.V.
- FranceSUNOSI 150 mg, comprimé pelliculéATNAHS PHARMA NETHERLANDS (PAYS-BAS)
- IrelandSunosi 150 mg film-coated tabletsAtnahs Pharma Netherlands B.V.
- IcelandSunosiAtnahs Pharma Netherlands B.V.
- NetherlandsSunosi 150 mg filmomhulde tablettenAtnahs Pharma Netherlands B.V.
- NorwaySunosiAtnahs Pharma Netherlands B.V.
- PolandSunosiAtnahs Pharma Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Sunosi
- Iceland · Sunosi
- Liechtenstein · Sunosi
- Norway · Sunosi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1a97394b-0627-415a-be2d-a69f4b65b6df GET /v1/drugs/1a97394b-0627-415a-be2d-a69f4b65b6df?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1613132599000}",
"nregistro": "1191408007",
"substance": "producto con solriamfetol"
}See everything about producto con solriamfetol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.